Two new observational studies add to the growing evidence base on cardiovascular risks associated with hormone replacement ...
The Autus surgically implanted device, made by Edwards Lifesciences, is also novel for its leaflets consisting of ePTFE.
A key message is that clinicians need to include nutrition discussions as part of routine care, Frank Hu says.
ESC 2026 captured the biggest share of our top slots, but readers were most keen to learn about the first FDA approval of ...
Experts urge clinicians to focus on stroke prevention benefits when counseling patients about carotid revascularization.
Mavacamten (Camzyos) is now approved by the US Food and Drug Administration for use not only in adults, but also in pediatric patients with obstructive hypertrophic cardiomyopathy (HCM) who weigh at ...
Identifying regions with expertise can improve how patients access those best at managing the disease, Richard Soucier says.
A retrospective analysis shows that when CMR and FDG PET/CT findings are concordant, patients are more vulnerable to events.
The data support the scalability of the strategy—still, an editorial urges that ethical concerns among the public can’t be ...
The US Food and Drug Administration has approved the Selution SLR sirolimus-eluting balloon for the treatment of coronary ...
New Zealand health technology startup HeartLab today announces its partnership with Australia’s largest private cardiology network, Advara HeartCare, to roll out its world-leading, cloud-based ...
Virtual reality calms claustrophobia, tweaking trial recruitment, multidisciplinary TAVI recovery efforts, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results